Breaking News
Early Sale 0
🐦 Early is the whole strategy. Up to 55% off on InvestingPro before Black Friday
Get Early Bird Access
Close

TheraCryf PLC (TCF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.170 0.000    0.00%
03:06:47 - Real-time Data. Currency in GBP
  • Volume: 764,705
  • Bid/Ask: 0.160 / 0.180
  • Day's Range: 0.170 - 0.170
Type:  Equity
Market:  United Kingdom
ISIN:  GB00BSVYN304 
SEDOL:  BSVYN30
TheraCryf 0.170 0.000 0.00%

TCF Recent Sentiments

 
This page features our users' sentiments regarding the TheraCryf PLC stock. They are displayed on both charts of different time periods and in a detailed table.
Start Date Username Call Open Rate End Date Chg. %
May 14, 2026 Stuart Little   0.250 May 14, 2026 @ 0.240 -4.00%
May 14, 2026 Stuart Little   0.250 May 14, 2026 @ 0.240 +4.00%
Feb 18, 2026 Martin Banister   0.240 Mar 13, 2026 @ 0.210 -12.50%
Feb 19, 2025 Martin Banister   0.310 Mar 14, 2025 @ 0.230 -25.81%
Jun 11, 2024 David Campbell   0.950 Jul 05, 2024 @ 0.850 -10.53%
Apr 29, 2024 Glen Bisson   0.850 May 06, 2024 @ 0.750 -11.76%
Jan 18, 2024 Glen Bisson   1.540 Jan 18, 2024 @ 1.540 0.00%
Dec 28, 2023 Glen Bisson   1.630 Dec 28, 2023 @ 1.630 0.00%
Nov 29, 2023 Glen Bisson   1.770 Dec 04, 2023 @ 1.700 -3.95%
Aug 15, 2023 David Campbell   2.730 Nov 30, 2023 @ 1.600 -41.39%
Jun 05, 2023 Kevin Wilson   3.940 Jun 05, 2023 @ 3.940 0.00%
Oct 13, 2022 Jimbo Mcg   4.720 Nov 04, 2022 @ 4.390 -6.99%
Oct 11, 2022 Richard Moss   6.600 Nov 04, 2022 @ 4.390 -33.48%
Oct 10, 2022 Ramlan Maulana   6.250 Oct 17, 2022 @ 4.700 -24.80%
Oct 10, 2022 Martin Banister   5.940 Nov 04, 2022 @ 4.390 -26.09%
Sep 15, 2022 Graham Butchart   3.680 Oct 07, 2022 @ 2.850 -22.55%
Aug 23, 2022 A Lakra   3.300 Aug 23, 2022 @ 3.390 -2.73%
Jul 09, 2021 Ozan Candir   5.200 Jul 30, 2021 @ 4.900 +5.77%
Jun 11, 2021 David Campbell   9.100 Jul 02, 2021 @ 8.000 -12.09%
May 04, 2021 Glen Bisson   7.920 May 10, 2021 @ 7.900 -0.25%
May 04, 2021 Glen Bisson   7.920 May 10, 2021 @ 7.900 -0.25%
May 04, 2021 Glen Bisson   7.920 May 10, 2021 @ 7.900 -0.25%
Apr 19, 2021 Glen Bisson   7.850 Apr 20, 2021 @ 7.940 +1.15%
Feb 16, 2021 Patrick Vosseler   9.200 Mar 12, 2021 @ 7.940 -13.70%
Jan 05, 2021 Patrick Vosseler   10.300 Jan 29, 2021 @ 9.400 -8.74%
Dec 08, 2020 John Rollings   8.500 Jan 01, 2021 @ 10.350 +21.76%
Nov 11, 2020 Donato Dagostino   8.190 Dec 04, 2020 @ 8.500 +3.79%
Oct 19, 2020 Pete Westlake   14.000 Nov 13, 2020 @ 8.290 -40.79%
Jul 21, 2020 Ben Smith   11.820 Aug 14, 2020 @ 15.000 +26.90%
Apr 14, 2020 shaun herbst   9.250 May 08, 2020 @ 11.400 +23.24%
Apr 14, 2020 francesco biliotti   8.500 May 08, 2020 @ 11.400 +34.12%
Apr 14, 2020 Al Mighty   7.420 Apr 17, 2020 @ 10.000 -34.77%
Jan 27, 2020 Patrick Vosseler   6.240 Feb 21, 2020 @ 4.800 +23.08%
Sep 23, 2019 Cato Stonex   16.640 Oct 18, 2019 @ 14.500 -12.86%
Aug 28, 2019 Craig Fletcher   16.900 Sep 20, 2019 @ 16.120 +4.62%
Mar 11, 2019 Patrick Vosseler   14.880 Apr 05, 2019 @ 18.060 +21.37%
Jan 22, 2019 Patrick Vosseler   15.750 Feb 22, 2019 @ 13.000 -17.46%
Oct 10, 2018 Ian Bainbridge   16.020 Nov 09, 2018 @ 13.000 -18.85%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TCF Comments

Write your thoughts about TheraCryf PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post 1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email